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Automated 3D US breast volume scanning M. Rutten; 's-Hertogenbosch/NL
Eliminating subjectivity and operator-dependent bias from ultrasound, automated breast volume scanning (ABVS), or 3D ultrasound (US), opens the door to new applications in mammary diagnostics and beyond. 3D US technique and scan methods as well as the post-processing, reviewing and analysing of the 3D breast US data sets are explained and illustrated. Our preliminary experience with clinical ABVS applications will be shown and the advantages, limitations and future aspects of ABVS will be discussed.
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Digital 3D breast tomosynthesis and its emerging role in breast cancer diagnosis J. Barkhausen; Lübeck/DE Breast cancer is the most common malignant tumour in women and early detection is most crucial for outcome and survival. Mammography is the most important imaging technique for tumour screening and characterisation of focal lesions. However, using plain film techniques the three-dimensional object is reduced to a two-dimensional image, and therefore small lesion may be undetectable due to superimposed glandular tissue. Recently, digital breast tomosynthesis (DBT) emerged as a new imaging modality to overcome this limitation. 25 low-dose mammographic projections using a standard mammography system are performed over a limited angle of 50 degree. Based on these images a stack of cross-sectional images covering the entire breast is reconstructed with an interslice distance of 1 mm. The glandular dose of a tomosynthesis scan is comparable to a standard mammography in two projections. Due to the lack of superimposed tissue tomosynthesis images significantly improve the visualisation of small focal lesions. Therefore, tomosynthesis is especially helpful in young women with mammographic dense breast tissue and in patients with fibrocystic breast disease, whereas the additional information is limited in fatty breast tissue. Furthermore, tomosynthesis allows better evaluation of focal lesions compared to conventional mammography. The detailed analysis of the lesions' border helps differentiating between summation artifacts, benign lesions and carcinomas. In conclusion, tomosynthesis will not replace conventional mammography in the near future, but provides clinically important additional information in difficult cases. Additionally, tomosynthesis has the potential to become the imaging modality of first choice in selected patients, e.g. with dense breast tissue. Learning Objectives:
1. To understand the technical principles of tomosynthesis. 2. To learn how tomosynthesis compares to conventional mammography. 3. To discuss which patients may benefit from tomosynthesis. The lecture aims at demonstrating the clinical value of a new 1.5T wide-bore whole body MR system equipped with the latest MRI pulse sequences and coils in the diagnostic of neurological, abdominal, pelvic, and musculoskeletal diseases. Special emphasis will be placed on the use of novel techniques such as contrast injected volumetric dynamic acquisitions in combination with fat/water separation methods in breast and liver oncology indications, NCE-MRA for the renal arteries, and motion-insensitive pulse sequences in abdomen and joints.
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In search for molecular imaging: the tri-modality imaging approach G.K. von Schulthess; Zurich/CH dual-energy arthrography is a promising tool for the evaluation of painful prosthesis. Digital x-ray tomosynthesis is a very low dose technique for producing slice images. The dose reduction is about 1/50 compared to CT-scan and its accuracy is superior to plain films in the diagnostic of subtle fractures. Metal artifacts do not affect it and the bone-metal interface can be well evaluated. The routine use of these techniques may drive significant cost savings in the imaging department. 
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Routine use of digital tomosynthesis for lung nodule detection: clinical, workflow and economic impacts
Since December 2006, two pulmonary nodule detection studies, enrolling 114 consenting patients and more than 4800 chest tomosynthesis examinations (TS) (VolumeRad, GE) have been performed at Sahlgrenska University Hospital, Göteborg, Sweden. The most frequent indications for TS have been suspicion of a nodule, tumour, pneumothorax, cavitation or possible confounding skeletal pathology seen on conventional chest radiography (CXR). CXR suffers from low sensitivity and specificity. Patients are often referred to computed tomography (CT) for further work-up of suspicious findings. CT often solves the problem, but has disadvantages such as high radiation dose and high costs. TS offers an improved chest radiography method, which can be used to select patients who need further investigation with CT, thereby significantly reducing radiation dose to population (at least by a factor of 20), optimising the use of CT resources and reducing operating costs in the department. However, TS showed some limitations, such as the requirement for patients to hold their breath for 10s and limited depth resolution of reconstructed images. In the clinical setting at our institution, TS is now routinely used as an adjunct examination to CXR to decide whether to recommend CT or not, based on the findings of the combination of CXR and TS. TS is also used in selected cases for follow-up of pathology which has been confirmed by CT. TS is currently requested by the referring clinicians in more than 50% of TS cases performed. Being part of routine care in our institution, TS is coded and reimbursed.
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Contrast-enhanced spectral mammography: clinical benefits in diagnostic workflow C. Dromain; Villejuif/FR Purpose: Quantify the additional clinical performance and derive the benefits of contrast enhanced spectral mammography (CESM) as an adjunct to standard of care (digital mammography (MX) and ultrasound (US)) in a diagnostic population of women. Materials and Methods: After ethics committee approval 120 consenting patients recalled for diagnostic work-up were imaged with MX, US and CESM. CESM examinations were performed using a GE Healthcare (Chalfont St-Giles, UK) Senographe DS system, modified for paired dual energy exposures (below and above the K-edge of iodine) as well as image recombination for contrast visualization with texture cancellation. Intra-venous injection of iodinated contrast agent (300mg/ml) followed a standard CT protocol (1.5ml/kg of weight at 3ml/s rate). Truth was checked for 112 patients with histology, cytology or minimum 1-year follow-up. Seven experienced breast radiologists blinded on truth and clinical history performed individual interpretations of MX, US and CESM images. Findings were localized and assessed with BI-RADS scores (0 not allowed). Areas under the ROC curves (Az), sensitivity and false positive fraction were calculated using BIRADS 4 as threshold for positive readings. Results: The dataset included a total of 150 proven lesions (86 malignant and 64 benign). Clinical performance (Az) with CESM increased for each reader and overall: areas under the ROC curves across the readers for MX+US and MX+US+CESM were 0.83 and 0.88 (p<0.05). Per lesion mean sensitivities for malignancies were 65.6% and 71.8% respectively (p<0.05) with a slight increase in the false marker rate per image: 0.49 for MX+US and 0.54 for MX+US+CESM. Conclusion: Addition of CESM to standard mammography and ultrasound significantly increased clinical performance and sensitivity across the readers. CESM should play a significant role as a problem solving and staging tool in the breast lesion diagnostic workflow. 
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Patient acceptance improvement with minimal bowel preparation in screening CT colonography J. Stoker; Amsterdam/NL CT-colonography is widely used in patients suspected of colorectal cancer. The technique is already used for screening in some countries and is a (potential) candidate for screening in other countries. Extensive bowel preparation is considered as the most burdensome part of the CT-colonography examination and therefore limited bowel preparation has been introduced. This bowel preparation concerns tagging of faecal residue with either iodine or barium, such that full cathartic cleansing is no longer mandatory. This limited bowel preparation is combined with a low fibre diet for homogenously tagged stool. Colonoscopy cannot be performed at the same day, except when additional cleansing is performed. Studies on limited bowel preparation have shown that the accuracy is comparable to extensive bowel preparation, while the acceptance is better. This is not only important for symptomatic patients but also is crucial for screening. Screening techniques are evaluated for their yield and cost effectiveness. Yield concerns the detection of important lesions multiplied by the attendance. A technique with a good acceptance will lead to a better adherence to a screening program and -with comparable accuracy -higher yield. This might prove crucial for CT-colonography to be widely accepted as a screening technique.
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Water-coloCT: an alternative imaging technique for colon cancer diagnosis P.-J. Valette; Lyon/FR CT is essential for the diagnosis of colonic diseases. Its contribution now extends to tumour or chronic inflammatory diseases. Two technical approaches are proposed to obtain the colonic distension: -air insufflation (in fact CO2), with three-dimensional reconstructions to perform a virtual colonoscopy, -water enema. An IV injection of iodine is then performed with image acquisition at the venous time. The main purpose of the water-coloCT is to reveal the existence of a colonic stenosis and/ or parietal lesions with precise description of the extent and aspect in favor of enhancement by iodine. Lymph nodes and metastases are also checked, for staging of the tumour. Various studies have demonstrated the excellent sensitivity (98%) of the water-coloCT for detection of colonic tumours including small lesions. More useful, is its near-perfect negative predictive value (99%). Because of its simplicity, water-coloCT finds its ideal indications in symptomatic patients but at risk for a real colonoscopy with general anesthesia. The addition of a simple water enema during scanners performed for assessment of inaugural liver metastases with unknown primary tumour makes also possible the immediate detection of the colonic origin if so. In practice, water-coloCT is therefore directed to symptomatic patients suspected of having colon cancer, and is a complementary technique of virtual colonoscopy in the screening of adenomatous polyps in non symptomatic patients.
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Dynamic MR imaging in liver staging after colon cancer T.J. Vogl, R. Hammerstingl; Frankfurt a. Main/DE Liver metastases are the most common cause for liver malignancy. High precision in detecting, localizing, and characterizing lesions in liver staging after colon cancer is important, because further treatment decision may have consequences for the prognosis of the patient. Improvements in imaging modalities have contributed to a better depiction, delineation and classification of tumors. Contrast-enhanced MR imaging has become an essential part of liver examination in a number of circumstances. Extracellular fluid space contrast agents are safe compounds in handling and provide information on vascularization and perfusion of focal liver tumors. A dynamic contrast-enhanced study of the liver is performed during the arterial, portal venous, and delayed phase of enhancement. Fast spoiled GRE allows thin-section imaging of the entire liver during a single breath-hold. New volumetric sequences have enabled three-dimensional dynamic imaging with a very high spatial and temporal resolution. The key issue of contrast agents in hepatic imaging is to discriminate between tissue that cannot be adequately differentiated on unenhanced MR imaging. Different characteristic features of the intravascular and extracellular spaces of the various focal liver lesions are depicted by extracellular gadolinium contrast agents. Dynamic imaging has also been shown to improve not only the distinction of malignant lesions but also to achieve the specific diagnosis for most liver tumors and to identify benign disease precisely. Peripheral rim-enhancement, wash-out effect, triangle and wedge sign are typical characteristics of metastases.
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Whole-body staging with contrast-enhanced PET-CT G. Antoch; Düsseldorf/DE Diagnostic potentials -as well as limitations -associated with morphological cross-sectional imaging on the one hand, and functional imaging on the other, are increasingly well understood. It has become obvious that in many cases both kinds of imaging complement one another. Therefore, hybrid PET/CT imaging must be considered one of the most important new developments in medical imaging in the past decade. When coupling PET with contrast-enhanced CT data whole-body staging of colorectal tumours may be accomplished in a single session offering both diagnostic CT and diagnostic PET data. However, some questions have to be raised and challenges have to be met to avoid overrating PET/CT when staging colorectal disease. The accuracy of PET using FDG as a radionuclide is only low when assessing the T-stage and N-stage of colorectal tumours. Specified PET/CT protocols, such as PET/CT-colonography, may increase this accuracy. However, the main indication for PET/CT in colorectal disease has been staging for distant metastases. In this setting FDG-PET/CT has been reported of high sensitivity with advantages over other imaging procedures. However, even in tumor staging FDG-PET/CT may have limitations in body regions such as the brain (high physiological FDG uptake) or the liver (breathing motion). This talk summarizes the indications of contrast-enhanced PET/CT in whole-body staging of colorectal tumors. Potential limitations of the imaging procedure will be addressed. 
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New aspects in tendon imaging A. Klauser; Innsbruck/AT Real-time tissue elastography in tendons: is there any value? Imaging has been used as a yardstick for diagnosing tendinopathies and in particular achillodynia, with MRI and US as the most commonly used modalities in clinical routine. However, in the literature, the value of these methods is somewhat controversial when compared with clinical assessment. The etiology of tendon disorders is believed to be multifactorial. Repetitive microtrauma and vascular alteration as well as hypoxic, mucoid, calcifying, and lipoid degenerations may lead to microscopic alterations, tendon thickening, partial tearing and subsequent full-thickness ruptures. Clinical differentiation between tendinopathy, partial tears, and even paratendinitis may be difficult, and therefore imaging is used, predominantly MRI and US. In the musculoskeletal field, real-time tissue elastography can help improve estimation of tendon stiffness, which might give additional information in the cycle of tendon degeneration to conventionally used imaging modalities. The usefulness of elastography can be expected to increase rapidly in the musculoskeletal field, as soon as we learn to interpret elastographic artifacts as well as to take advantage of the new information provided by real-time tissue elastography. Preliminary findings of real-time tissue elastography in healthy and pathological Achilles tendons, technical considerations, examination technique and several limitations will be addressed.
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Hitachi real-time tissue elastography in radiology P.S. Sidhu; London/UK Real-time tissue elastography of the testis -a useful tool? Ultrasound is the 'gold-standard' of imaging of the scrotal sac and is unparalleled in that in almost all instances it out-performs other imaging modalities. The development of highfrequency transducers and exquisitely sensitive colour Doppler methods has revolutionised the assessment of the scrotal contents. Nevertheless, clinical palpation remains the cornerstone of diagnosis particularly in the assessment of the testicular tumour, deciding whether malignancy is present. Newer technology introduced to ultrasound, and in use in other areas of the body, may find an application in the scrotal sac. Real-time tissue elastography may scrutinise the lesion within the testis, particularly the small indeterminate intra-testicular lesion, and characterize the 'hardness' aiding management and perhaps avoiding unnecessary surgery or orchidectomy. Areas of ischaemic change and scarring, demonstrating different elastography patterns from tumour, may be identified with added confidence. Global testicular disease causing fibrosis and infertility may present characteristic patterns on elastography, avoiding testicular biopsy for confirmation. This presentation will demonstrate the various appearances of testicular pathology on real-time tissue elastography, indicating areas where this technique may be useful and suggesting areas for further research and eventual clinical utility.
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Non-invasive evaluation of liver fibrosis using Hitachi real-time tissue elastography K. Fujimoto; Tanabe/JP Assessment of liver fibrosis stage using the liver fibrosis index (LF Index). Within the long-term scenario of chronic hepatitis C, the relationship between the risk of hepatocellular carcinoma and the stage of liver fibrosis has been reported. Thus histological diagnosis by liver biopsy is important to evaluate the stage of hepatic fibrosis; however, it is an invasive technique. Previously, measurement of platelet count and liver fibrosis markers have been used as non-invasive tests to evaluate liver fibrosis, combined with diagnostic imaging methods such as ultrasonography. Recently, real-time tissue elastography (RTE) has been developed. This technique has implemented the combined autocorrelation method for the high-speed calculation and real-time colour display of relative tissue stiffness derived from tissue strain. We have examined the accuracy of RTE for the evaluation of liver fibrosis in chronic hepatitis C and reported that the liver elasticity score, which was scored visually, significantly increased as fibrosis stage progressed and reflected the degree of liver fibrosis. We performed RTE on 310 patients with chronic hepatitis C (and/ or liver cirrhosis) and 15 healthy volunteers. Nine image features were extracted from each RTE image and a multiple regression analysis was performed to derive the regression equation. This equation calculates a liver fibrosis index (LF Index), which in turn predicts the fibrosis (F) stage of the liver. LF Index not only correlates highly with the F stage (r=0.68), but also it shows significant differences in LF Index values (p<0.001) between each stage of fibrosis. As a result, it was possible to assess liver fibrosis stage non-invasively using elastography. The liver fibrosis index (LF Index) highly correlated with histological assessment of liver fibrosis stage. 
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New clinical data to support DCE-US as the imaging modality for the monitoring of anti-angiogenesis therapies efficacy N. Lassau; Villejuif/FR
The early functional evaluation of new treatments is a main goal. At present, technical advances in DCE-ultrasonography using bolus contrast agent (SonoVue®, Bracco) and perfusion software allow the detection of micro-vascularisation and perfusion of superficial and deep malignant tumours. Thus, it becomes possible to early evaluate the efficiency of antiangiogenic or anti-vascular molecules. Treatment response can be early predicted according to modifications of this vascularisation before any volume modification. The acquisition of raw linear data affords the precise quantification (peak intensity, time to peak intensity, slope of wash-in, and area under the curve, etc.) of the perfusion after contrast uptake curves modelisation, particularly using time tracking of region of interest. The results obtained in our institution on 117 patients, will be focused on GIST, RCC, HCC, and melanoma treated with different molecules. Reduction in tumour vascularisation can easily be detected in responders after 1 or 2 weeks and is correlated with progression-free survival and overall survival in RCC or HCC. DCE-US is supported by the French National Cancer Institute (INCa), which is currently studying the technique in metastatic breast cancer, melanoma, colon cancer, gastrointestinal stromal tumours and renal cell carcinoma, as well as in primary hepatocellular carcinoma, to establish the optimal perfusion parameters and timing for quantitative anticancer efficacy assessments. Final results: 539 patients evaluated in 19 centers with more than 2000 DCE-US demonstrating that AUC could be a robust parameter to predict response.
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Evaluation of the clinical impact of CEUS in the treatment of abdominal aneurysm V. Cantisani; Rome/IT Endovascular aneurysm repair (EVAR) is an effective alternative treatment to open repair of abdominal aortic aneurysm and the number of EVAR procedures carried out worldwide is continuously growing. Incomplete exclusion of the aneurysm sac from the circulation, defined as endoleak, is the most frequent complication after EVAR occurring in 10% to 45% of cases, and it can be associated with aneurysm enlargement and possibly rupture. Despite its notable advantages, ultrasonography
has not yet achieved reference standard status in the EVAR follow-up because of low diagnostic specificity and sensitivity. Recent studies on ultrasound examinations performed without echo-contrast agents reported sensitivity rates ranging from 43% to 97%, such wide differences suggesting that it does not guarantee the necessary reliability (4,5). Therefore, to date computed tomography angiography (CTA) is the preferred imaging modality to follow-up patients after EVAR. However, CTA surveillance carries the risks associated with radiation and contrast media exposure. Magnetic resonance angiography (MRA) and contrast-enhanced ultrasonography (CEUS) have been shown in some studies a better accuracy than CTA (6, 7-13). However, there is no consensus with regard of optimal work-up with diagnostic imaging modalities in surveillance after EVAR. The accuracy of current imaging modalities in the detection and characterisation of endoleaks in aortic endografts, focusing especially on the accuracy of CEUS with the use of second generation contrast agent have been presented. The advantages, the limitations of CEUS in comparison with CTA and MRA, will be discussed. 
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Reducing CT dose in myocardial perfusion SPECT/CT E. O'Shaughnessy; Poole/UK Aims: To reduce the CT dose for attenuation correction to SPECT studies as much as possible without adversely affecting its accuracy. Methods: Using the Perspex CTDI phantom with the Xi detector to measure dose, CT scans were acquired using the Siemens Symbia T over the range of CareDOSE settings. Using the default setting 'ACEmean' the measured dose at the centre of the phantom was 1.675mGy and the breast dose from the topogram was 0.3mGy. The lowest dose was achieved using the setting 'DOM' where the doses were reduced to 1.205mGy and undetectable respectively. To observe the effect of changing these settings, 30 patients received a stress scan with default CT settings and a rest scan utilising SPECT guided CT and the new settings.
